Get the content you want anytime you want.
ID Week 2018

Select coverage from ID Week 2018 is included below:

<i>Candida</i> Epidemiology:  Non-<i>albicans</i> Infections Are On the Rise
Emily Ricotta, PhD, ScM, highlights the increase in non-albicans candidiasis, which tends to be more antibiotic resistan,t in both bloodstream and sterile-site infections.
Advancements in the Field of Blood Culture Testing
Melvin Weinstein MD, discusses the emerging technologies that will advance the field of blood culture testing.
Penicillin Allergies: Debunking Myths
Julie Ann Justo, PharmD, discusses the myths associated with penicillin allergies and why it is important to determine a patient's true penicillin allergy-status.
Treating Immunocompromised Patients with Hepatitis B
Kenneth Sherman, MD, discusses hepatitis B infections in immunocompromised patients and what clinicians should expect to see in the future for hepatitis B treatment.
Addressing Shortcomings in Infection and Sepsis Treatment Should Be Top of the Priority List
As clinicians and health care executives work to strike a balance between reducing costs and improving clinical outcomes, the importance of sepsis identification and treatment cannot be underscored enough, and starts with evaluating current practices for infection management.
The Fight Against Resistance: Shorter is Better
Brad Spellberg, MD, highlights research that indicate shorter courses of therapy are safer and as effective as longer ones, as well as the importance of randomized controlled trials.
High <i>Toxocara</i> Egg Contamination Found in Areas of Pennsylvania Parks
Highest amounts of Toxocara egg contamination were in areas that could contain food droppings or animal waste.
Iclaprim Non-Inferior to Vancomycin in Treating Patients with Wound Infections
Data from a pooled analysis of the REVIVE-1 and 2 studies found iclaprim to be non-inferior to vancomycin based on earl clinical response in patients with wound infections.